FDA approves sorafenib for patients with inoperable liver cancer

Gastroenterology. 2008 Feb;134(2):379. doi: 10.1053/j.gastro.2007.12.037.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Drug Approval
  • Humans
  • Liver Neoplasms / drug therapy*
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyridines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Sorafenib
  • United States
  • United States Food and Drug Administration*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib
  • Protein-Tyrosine Kinases